COMMUNIQUÉS West-GlobeNewswire

Capital Increase in Genmab as a Result of Employee Warrant Exercise

28/02/2018 - 18:31

Company Announcement Copenhagen, Denmark; February 28, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 65,419 shares as a consequence of the exercise of employee warrants. The increase is [...]

NÉOVACS RENFORCE SA STRUCTURE FINANCIÈRE À HAUTEUR DE 1 M€ PAR PLACEMENT PRIVÉ ET À HAUTEUR DE 3,8 M€ PAR UNE ÉMISSION OBLIGATAIRE CONVERTIBLE

28/02/2018 - 18:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS RENFORCE SA STRUCTURE FINANCI È RE À HAUTEUR DE 1 M€ PAR PLACEMENT PRIV É ET À HAUTEUR DE 3,8 M€ PAR UNE É MISSION OBLIGATAIRE CONVERTIBLE Paris [...]

OSE Immunotherapeutics Presenting at the Annual International Conference BIO-EUROPE SPRING®

28/02/2018 - 18:00

Amsterdam, March 12-14, 2018 NANTES, France, Feb. 28, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), announces it will be featured as a presenting company at the 12th Annual Conference [...]

Bringing Intelligence to Heart Sounds, Eko Closes $5 Million Series A Led by ARTIS Ventures

28/02/2018 - 18:00

Berkeley, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Eko , the leader in acoustic cardiac monitoring, today announced a $5 million Series A led by ARTIS Ventures . Additional investors in the round include Strategic Partners, [...]

Market for analytical and life science instruments projected to grow by 4.6%

28/02/2018 - 17:23

LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Strategic Directions International (SDi), a division of BioInformatics LLC, today announced the release of the 2018 Global Assessment Report: The Laboratory Analytical [...]

Consolidated Sales of Olainfarm Reached 122 Million Euros

28/02/2018 - 17:15

Olaine, 2018-02-28 17:15 CET (GLOBE NEWSWIRE) -- “Successful operations of the Company in future will largely depend on its ability to diversify its sales markets and products and to preserve its current position in its [...]

Metabolon Launches Meta UDx™ Test to Speed Diagnosis of Rare and Undiagnosed Diseases in Children and Adults

28/02/2018 - 16:50

Meta UDx provides in-depth metabolic information and new insights for difficult-to-diagnose patient cases Expanding LDT clinical testing portfolio demonstrates value of clinical metabolomics for rare and undiagnosed [...]

Tabula Rasa HealthCare to Announce Fourth Quarter and Full Year 2017 Operating Results and Host Conference Call on Monday, March 12, 2018

28/02/2018 - 16:00

MOORESTOWN, N.J., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software [...]

Client Outlook Announces Partnership with InTouch Health to Deliver Next Generation Telehealth Image Viewing Solution

28/02/2018 - 16:00

WATERLOO, Ontario, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Client Outlook, leading developer of healthcare imaging solutions, announced today the planned integration of its eUnity diagnostic and clinical image viewing [...]

Endocyte Announces Pricing of Public Offering of Common Stock

28/02/2018 - 15:18

WEST LAFAYETTE, Ind., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq Global Market:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today the [...]

Predictive Technology Group, Inc. (PRED) Retains Donohoe Advisory Associates, LLC to Assist in Preparing to Seek a Listing on a National Securities Exchange

28/02/2018 - 15:15

SALT LAKE CITY, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED) announces that it has engaged Donohoe Advisory Associates , LLC (“Donohoe Advisory”) in connection with its efforts to [...]

Editas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases

28/02/2018 - 15:00

CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced the Company has joined forces with 30 million Americans and health care [...]

Flexion Therapeutics to Present at the 39th Annual Raymond James Institutional Investors Conference

28/02/2018 - 15:00

BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, will present at the Raymond James 39 th [...]

CV Sciences, Inc. to Present at the 30th Annual ROTH Conference in Dana Point, California, March 11-14, 2018

28/02/2018 - 14:45

LAS VEGAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that it will be presenting at [...]

BioNews Services Puts Sharp Focus on Rare Disease Day 2018

28/02/2018 - 14:45

DALLAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- BioNews Services , the leading online health, science and research publisher serving patients with rare diseases, is using its editorial resources this month in conjunction with [...]

PositiveID Announces Medical Device Subsidiary 2018 Trade Show Schedule

28/02/2018 - 14:37

DELRAY BEACH, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Diversified life sciences company, PositiveID Corporation (OTC:PSID), today announced the list of 2018 trade shows its wholly owned, professional-grade thermometer [...]

Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call

28/02/2018 - 14:30

WOBURN, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience,Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and host a conference [...]

AzurRx BioPharma to Present at the 30th Annual ROTH Conference (March 12th)

28/02/2018 - 14:30

BROOKLYN, N.Y., Feb. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

LeMaitre Vascular to Present at Upcoming Investor Conferences

28/02/2018 - 14:30

BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will be participating in seven investor conferences in March. Steven Chehames, Investor Relations, [...]